Department of Brain Sciences, Imperial College London, London, UK
Department of Psychiatry, Puerta de Hierro University Hospital, Majadahonda, Spain.
BMJ Open. 2024 Nov 27;14(11):e088129. doi: 10.1136/bmjopen-2024-088129.
We aimed to estimate the incidence of avoidant/restrictive food intake disorder (ARFID) in children and adolescents (CA) presenting to secondary care in the UK and Republic of Ireland (ROI).
This observational surveillance study used the British Paediatric Surveillance Unit and the Child and Adolescent Psychiatry Surveillance System. Monthly electronic reports were submitted by consultant paediatricians and child and adolescent psychiatrists from 1 March 2021 to 31 March 2022, with outcomes assessed at a 1-year follow-up.
The UK and ROI.
Clinician-reported data on children and young people aged 5-17 (inclusive) in contact with paediatric services or CA mental health services for a new diagnosis of ARFID.
Annual incidence rates (IRs) estimated as confirmed new cases per 100 000 population at risk.
319 newly diagnosed cases of ARFID were reported over the 13-month surveillance period and assessed as eligible for inclusion. The mean age of the sample was 11.2 years (SD=3.8). The sample consisted of 145 females (45.5%). Most cases were of white British ethnicity (71.2%). The observed IR (IR0) in the UK was 2.79 per 100 000 CA (95% CI 2.48 to 3.13), with a higher IRo in males (2.98 per 100 000 CA (95% CI 2.55 to 3.49)) than in females (2.58 per 100 000 CA (95% CI 2.18 to 3.07)). Comorbidity was common in this sample with anxiety and autism spectrum disorder. At follow-up, 54.8% of cases had improved according to clinicians' clinical impression.
We conducted the first study reporting estimates of incidence of ARFID in CA in the UK and ROI presenting to secondary care. Our finding that ARFID is a disorder of relatively low incidence in CA should help inform service planning and resource allocation, as well as the development of evidence-based interventions.
我们旨在估计在英国和爱尔兰共和国(ROI)接受二级保健的儿童和青少年(CA)中出现回避/限制型食物摄入障碍(ARFID)的发生率。
本观察性监测研究使用了英国儿科监测单位和儿童和青少年精神病学监测系统。顾问儿科医生和儿童和青少年精神病医生每月提交电子报告,从 2021 年 3 月 1 日至 2022 年 3 月 31 日,结果在 1 年随访时进行评估。
英国和 ROI。
临床医生报告的数据涉及 5-17 岁(含)的儿童和年轻人,他们因新诊断的 ARFID 而与儿科服务或 CA 心理健康服务接触。
估计为每 100000 名风险人群中有确诊新病例的年度发病率(IR)。
在 13 个月的监测期间报告了 319 例新诊断的 ARFID 病例,并评估为符合纳入标准。样本的平均年龄为 11.2 岁(SD=3.8)。样本由 145 名女性(45.5%)组成。大多数病例为白种英国人种(71.2%)。英国的观察到的发病率(IR0)为每 100000 名 CA 2.79(95%CI 2.48 至 3.13),男性的发病率(每 100000 名 CA 2.98(95%CI 2.55 至 3.49))高于女性(每 100000 名 CA 2.58(95%CI 2.18 至 3.07))。该样本中焦虑症和自闭症谱系障碍的合并症很常见。在随访时,根据临床医生的临床印象,54.8%的病例有所改善。
我们进行了第一项报告在英国和 ROI 二级保健中接受治疗的 CA 中 ARFID 发病率估计的研究。我们发现 ARFID 在 CA 中是一种发病率相对较低的疾病,这应该有助于为服务规划和资源分配提供信息,并为基于证据的干预措施的发展提供信息。